Penn Life Company Profile
What is the competitive landscape for PENN LIFE
PENN LIFE has four approved drugs.
Drugs and US Patents for Penn Life
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Penn Life | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | INJECTABLE;INJECTION | 215542-001 | Sep 20, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Penn Life | CARMUSTINE | carmustine | INJECTABLE;INJECTION | 209278-001 | Apr 2, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Penn Life | THIOTEPA | thiotepa | INJECTABLE;INJECTION | 208242-001 | Jan 10, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Penn Life | ARSENIC TRIOXIDE | arsenic trioxide | INJECTABLE;INJECTION | 209873-001 | May 6, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

